Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting125%
completed375%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Collection of Information to Better Understand Young Onset Colorectal Cancer

NCT04489238
completed

Cancer Loyalty Card Study

NCT03994653
completed

Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda

NCT05698537
completednot_applicable

Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)

NCT00927485

Clinical Trials (4)

Showing 4 of 4 trials
NCT04489238

Collection of Information to Better Understand Young Onset Colorectal Cancer

Recruiting
NCT03994653

Cancer Loyalty Card Study

Completed
NCT05698537

Risk Factors and Etiologies of Epilepsy in Urban and Rural Rwanda

Completed
NCT00927485Not Applicable

Use of Curcumin for Treatment of Intestinal Adenomas in Familial Adenomatous Polyposis (FAP)

Completed

All 4 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
4